This book offers the necessary information for patients diagnosed with chronic lymphocytic leukemia (CLL) to engage in meaningful conversations with their healthcare providers. It empowers them to make informed decisions about managing their condition. Download this e-book to provide your patients with a deeper understanding of their illness.
Category: Reading
This book offers the necessary information for patients diagnosed with marginal zone lymphoma (MZL) to engage in meaningful conversations with their healthcare providers. It empowers them to make informed decisions about managing their condition. Download this e-book to provide your patients with a deeper understanding of their illness.
This book offers the necessary information for patients diagnosed with follicular lymphoma (FL) to engage in meaningful conversations with their healthcare providers. It empowers them to make informed decisions about managing their condition. Download this e-book to provide your patients with a deeper understanding of their illness.
Factsheet summarising the long-term follow-up data of the ASPEN trial, a Phase 3 study of zanubrutinib vs ibrutinib in Waldenström’s macroglobulinemia (WM) patients.
Factsheet describing the results of the PFS final analysis of the ALPINE trial, a Phase 3, randomized study of zanubrutinib compared with ibrutinib in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL).



